Funding Report: The Life Science funding landscape in Sweden 2015-2019

June 16, 2020

Industrifonden has reviewed the funding flows into Swedish life science companies, focusing on Therapeutics, HealthTech, Diagnostics and Medtech, over the last five years (2015-2019). The report covers funding across the life cycle, from grants, to incubator and angel funding, on to venture capital (VC) and the stock markets; the amounts increase for each step. During this 5-year period, a handful of successful exits, some public, some private, generated funding flows back to investors of about 22 bnSEK. With 35 bnSEK recently invested – exciting times ahead!

Read the full report here

The authors of the report are Ester Sklarsky and Jonas Jendi.

By continuing on the site you accept our terms and conditions for cookies. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.